Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
From Estonia to Antarctica, this once-pagan symbol has taken on many strange forms. In December 1848, an illustration showed Queen Victoria, Prince Albert, and their children admiring a Christmas tree ...
The best artificial Christmas trees dazzle your home without the cleanup and maintenance required of a real tree. They also offer features no live tree can offer: the ability to re-use your tree year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback